
==== Front
BMC Med
BMC Med
BMC Medicine
1741-7015
BioMed Central London

39289682
3632
10.1186/s12916-024-03632-4
Research
Diurnal timing of physical activity and risk of colorectal cancer in the UK Biobank
http://orcid.org/0000-0002-1120-1751
Stein Michael J. michael.stein@ukr.de

1
http://orcid.org/0000-0002-9265-5594
Baurecht Hansjörg 1
http://orcid.org/0000-0002-0931-8651
Bohmann Patricia 1
http://orcid.org/0000-0003-3498-6499
Fervers Béatrice 23
Fontvieille Emma 4
http://orcid.org/0000-0001-8648-4998
Freisling Heinz 4
http://orcid.org/0000-0002-4783-1966
Friedenreich Christine M. 56
http://orcid.org/0000-0002-4232-4105
Konzok Julian 1
http://orcid.org/0000-0001-8742-8920
Peruchet-Noray Laia 47
http://orcid.org/0000-0002-7564-3065
Sedlmeier Anja M. 189
http://orcid.org/0000-0002-0371-2789
Leitzmann Michael F. 1
http://orcid.org/0000-0002-4777-7808
Weber Andrea 1
1 https://ror.org/01eezs655 grid.7727.5 0000 0001 2190 5763 Department of Epidemiology and Preventive Medicine, University of Regensburg, Franz-Josef-Strauß-Allee 11, Regensburg, 93053 Germany
2 https://ror.org/01cmnjq37 grid.418116.b 0000 0001 0200 3174 Département Prévention Cancer Environnement, Centre Léon Bérard, Lyon, France
3 INSERM U1296 Radiations: Défense, Santé, Environnement, Lyon, France
4 https://ror.org/00v452281 grid.17703.32 0000 0004 0598 0095 International Agency for Research On Cancer (IARC), Nutrition and Metabolism Branch, 25 Avenue Tony Garnier, CS90627, Lyon, 69366 France
5 https://ror.org/02nt5es71 grid.413574.0 0000 0001 0693 8815 Department of Cancer Epidemiology and Prevention Research, Alberta Health Services, Calgary, AB Canada
6 https://ror.org/03yjb2x39 grid.22072.35 0000 0004 1936 7697 Departments of Oncology and Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB Canada
7 https://ror.org/021018s57 grid.5841.8 0000 0004 1937 0247 Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Barcelona, Spain
8 https://ror.org/01226dv09 grid.411941.8 0000 0000 9194 7179 Center for Translational Oncology, University Hospital Regensburg, Regensburg, 93053 Germany
9 Bavarian Cancer Research Center (BZKF), Regensburg, 93053 Germany
18 9 2024
18 9 2024
2024
22 39929 2 2024
12 9 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Background

Physical activity reduces colorectal cancer risk, yet the diurnal timing of physical activity in colorectal cancer etiology remains unclear.

Methods

This study used 24-h accelerometry time series from UK Biobank participants aged 42 to 79 years to derive circadian physical activity patterns using functional principal component analysis. Multivariable Cox proportional hazard models were used to examine associations with colorectal cancer risk.

Results

Among 86,252 participants (56% women), 529 colorectal cancer cases occurred during a median 5.3-year follow-up. We identified four physical activity patterns that explained almost 100% of the data variability during the day. A pattern of continuous day-long activity was inversely associated with colorectal cancer risk (hazard ratio (HR) = 0.94, 95% confidence interval (CI) = 0.89–0.99). A second pattern of late-day activity was suggestively inversely related to risk (HR = 0.93, 95% CI = 0.85–1.02). A third pattern of early- plus late-day activity was associated with decreased risk (HR = 0.89, 95% CI = 0.80–0.99). A fourth pattern of mid-day plus night-time activity showed no relation (HR = 1.02, 95% CI = 0.88–1.19). Our results were consistent across various sensitivity analyses, including the restriction to never smokers, the exclusion of the first 2 years of follow-up, and the adjustment for shift work.

Conclusions

A pattern of early- plus late-day activity is related to reduced colorectal cancer risk, beyond the benefits of overall activity. Further research is needed to confirm the role of activity timing in colorectal cancer prevention.

Supplementary Information

The online version contains supplementary material available at 10.1186/s12916-024-03632-4.

Keywords

Physical activity patterns
Colorectal cancer
UK Biobank
Raw accelerometry
Universität Regensburg (3161)Open Access funding enabled and organized by Projekt DEAL.

issue-copyright-statement© BioMed Central Ltd., part of Springer Nature 2024
==== Body
pmcBackground

The global prevalence of insufficient physical activity in 2016 was 28%, with a higher rate (37%) in high-income countries [1, 2]. There is substantial evidence of a dose–response relation between increasing levels of physical activity and decreasing incidence of at least 10 different cancers including colorectal cancer [3]. Whilst evidence has accumulated on the type, dose, and time periods in life when physical activity is associated with reduced cancer risk, the specific impact of its timing during the day is poorly understood.

Diurnal timing of exercise impacts muscle metabolism [4] and may influence cardiometabolic processes that play a role in carcinogenesis [3]. Recent studies have explored its association with various health outcomes, yielding diverse findings [5]. Mid-day or afternoon activity has been associated with lower blood glucose levels [6–8] and decreased mortality [9]. Evening activity has been linked to improved cardiometabolic health markers [10–12] and a lower body mass index (BMI) [13]. Morning activity has yielded inconsistent results with cardiovascular disease; one study suggested a decreased risk [14], while another indicated an increased risk [15]. The evidence for an association between time-of-day specific activity with cancer risk is sparse and inconsistent. One study reported decreased colorectal cancer risk with morning and afternoon activity [16], whereas other investigations found no relations of activity timing to risks of breast and prostate cancer [17] or cancer mortality [9].

Device-based measurement of physical activity, increasingly common in health research [16], facilitates the assessment of diurnal physical activity timing. However, available research using accelerometer-based assessments for activity timing in relation to cancer is very limited and has faced challenges such as the need for a priori assumptions in clustering algorithms [16] and the risk of overfitting with dataset-specific time windows [9].

To address those issues, we used functional principal component analysis (fPCA) to assess diurnal activity patterns and their relations to colorectal cancer. Given the limited evidence for the effects of diurnal timing of physical activity on cancer risk, we focused on a malignancy that is remarkably responsive to physical activity as a preventive measure [18], hypothesizing that potential associations are most likely to occur here. fPCA extends PCA to handle functions or curves as observations, efficiently reducing data complexity without pre-set assumptions. Our aim was to overcome previous methodologic limitations and identify specific times of day when physical activity is potentially most effective in preventing colorectal cancer.

Methods

Study population and data collection

The UK Biobank, a prospective cohort study, enrolled over 500,000 UK participants aged 40 to 69 years between 2006 and 2010. The study collected sociodemographic, lifestyle, and extensive phenotypic data, using touchscreen questionnaires, interviews, physical and functional measurements, and biomaterials collection. Ethical approval was obtained from the North West Multi-Centre Research Ethics Committee. All participants provided written informed consent [19].

Physical activity assessment and patterns

In a subset of over 103,000 randomly selected participants, device-based physical activity was measured between 2013 and 2015 using an Axivity AX3 wrist-worn triaxial accelerometer (Newcastle Upon Tyne, UK). Participants were instructed to wear the accelerometer on their dominant wrist continuously for seven days from activation soon after receiving it, and then to return the device to the coordinating center. A UK Biobank expert group processed data to derive the Euclidean norm minus one (ENMO) from accelerometry data [20], a summary metric of bodily acceleration in milligravity units (mg), interpretable as physical activity volume. Inclusion criteria included data with good calibration and from at least 72 h, covering each hour of the day on multiple days. Those with daily ENMOs above the 99.9th percentile were excluded, leaving 96,568 participants (Additional file 1: Supplement S1). These data formed a 96,568 × 24 matrix of average hourly acceleration.

Functional principal component analysis

We estimated standardized residuals of the 24-h ENMO time series using linear regression adjusted for age, sex, and study region to address major confounding a priori. These residuals underwent fPCA to reduce data dimensionality while retaining between-person variation. Individuals’ fPC scores indicated how closely a participant’s activity data matched a specific pattern (eigenfunction) [21]. fPCA was implemented using principal analysis by conditional estimation (PACE) suitable for sparse longitudinal data [22]. Gaussian kernel smoothing with default bandwidth estimation (5% of the observed time range for the mean function; 10% for the covariance function) was applied. Robustness was assessed through sensitivity analyses using generalized cross-validation for bandwidth selection along with an alternative kernel smoothing method. The Epanechnikov kernel was chosen for its compactness and performance. The number of relevant components was determined using the elbow method, a > 95% variability threshold, and visual inspection of fPCs [23].

To identify activity patterns that encompass all movements captured by the accelerometer, including very low-intensity activity, we applied fPCA to time series accelerometry data. This method calculates multiple components, with each participant assigned a score for each component, indicating their alignment with respective patterns. Scores are either positive or negative, reflecting the degree to which a participant’s activity matches the periods when the fPC curve is positive or negative. A more extreme score signifies stronger adherence to that activity pattern, allowing for a comprehensive interpretation of individual activity behaviors in relation to these identified patterns.

Cohort follow-up and ascertainment of cancer cases

Participants’ vital status was obtained through linkage with health care data and national death registries [24]. Follow-up began at the baseline accelerometry measurement (June 2013–December 2015) and ended at cancer diagnosis, complete follow-up (February 2020 for England/Wales, January 2021 for Scotland) [25], loss to follow-up, or death, whichever came first. We focused on colorectal cancer incidence given convincing evidence for its relation to physical activity [18]. Colorectal cancer was classified using International Classification of Diseases (ICD-10) codes C18, C19, and C20. Only the first primary cancers were considered.

Covariates

Potential confounding covariates were identified using evidence-derived directed acyclic graphs and the disjunctive cause criterion [26] (Additional file 1: Supplement S2). Covariate details are given in Additional file 1: Supplement S3. Briefly, we stratified by sex, study region (England, Scotland, Wales), and age at accelerometry (10-year increments), and further adjusted for BMI (kg/m2), height (cm), smoking (pack years), alcohol use (grams per day [27]), self-reported sedentary behavior (hours) (as continuous variables), socio-economic status (Townsend index), education (College/University Degree; Higher National Diploma, A-level, other professional qualifications; General Certificate of Secondary Education, O-level; or none), diet (healthy diet score [28], 0–7 scale) (as categorical variables), hormone therapy among women, history of cardiometabolic disease, family history of colorectal cancer, and history of bowel cancer screening (as binary variables).

Statistical analysis

Statistical analysis included 86,252 participants after excluding 10,316 with prevalent malignant cancers (except non-melanoma skin cancer, Additional file 1: Supplement S1).

To address missing covariate data (0.1% to 15%, Additional file 1: Supplement S4), multiple imputation using chained equations was applied (ten datasets with five iterations each). This imputation involved predictive mean matching for continuous variables, logistic regression for binary variables, polytomous logistic regression for nominal variables, and proportional odds models for ordinal variables. Convergence and plausibility of the imputation were assessed visually [29].

We conducted Cox proportional hazard regression with age as the underlying time metric [30] and mutual adjustment for the four fPCs modeled as continuous variables. We fitted three models: model 1 (sex, study region, age), model 2 (all covariates except BMI), and model 3 (model 2 plus BMI). We estimated hazard ratios (HRs) and corresponding 95% confidence intervals (CIs) for associations between fPC scores and cancer, comparing scores of + 1 (activity during hours with a positive fPC curve) and − 1 (activity during hours with a negative fPC curve) to a score of 0 (not fitting the fPC). For ease of interpretation, we reversed positive scores to consistently yield inverse associations. We estimated p-values using a Wald test and a 5% statistical significance level. Non-linearity was addressed using restricted cubic splines with four knots at the 0.05, 0.35, 0.65, and 0.95 quantiles. Departures from linearity were assessed by testing whether the coefficient of the second and third spline transformation equaled zero [30]. Proportional hazards assumptions were checked using Schoenfeld residuals, and none of the model assumptions was violated. Additionally, we examined Pearson and Spearman correlations between activity patterns and selected biomarkers, including glucose, glycated hemoglobin (HbA1c), high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, estradiol, and insulin-like growth factor-1.

We conducted several sensitivity analyses to ensure the result robustness. These included disregarding the initial two follow-up years to address reverse causation, focusing on never-smokers to assess smoking-related confounding, analyzing colon and rectal cancer risk separately for anatomic site differences, examining potential collider bias by not adjusting for cardiometabolic disease, and exploring effect modification of the fPCA-cancer relations by all covariates to avoid missing subgroup associations. Additionally, we incorporated shift work in the model to investigate circadian rhythm disruptions. We also tested various fPCA hyperparameters (kernel smoother and bandwidths) and examined correlations with sleep, sedentary time, light, and moderate-to-vigorous activity proportions to evaluate activity pattern robustness.

All data processing and statistical analyses were performed using R 4.2.3 [31]. Specifically, fPCs were generated using the fdapace package [32], multiple imputation was conducted using the mice package [29], and Cox regression was performed using the rms package [33].

Results

Among 86,252 participants (56% women) aged 61.5 years at accelerometry, 529 colorectal cancer cases were ascertained during 5.3 years of follow-up. We derived four fPCs explaining almost 100% of accelerometry data variability. The first pattern (fPC1, 70%) denoted day-long activity, fPC2 (17%) characterized late-day activity, fPC3 (9%) signified early- plus late-day activity, and fPC4 (4%) represented mid-day plus night-time activity (Fig. 1A). Further details on how fPC scores relate to activity over time are shown in Fig. 1B and Additional file 1: Supplement S5.Fig. 1 A Four distinct previously derived physical activity patterns from functional principal component analysis. B Average hourly physical activity (PA) for positive scores (dashed line; > 1 standard deviation above the mean score), negative scores (dotted line; < 1 standard deviation below the mean score), and population average (solid gray line), for each functional principal component

Table 1 presents baseline population characteristics by fPC score quartiles. Participants with higher scores on fPC1 (day-long activity) tended to show a healthier lifestyle, characterized by greater overall acceleration, lower BMI, reduced smoking habits, a healthier diet, less sedentary behavior, and lower prevalence of cardiometabolic diseases, relative to participants with lower scores. Those with fPC2 scores signifying late-day activity had a slightly healthier profile compared to those with early-day activity. This was due to higher overall acceleration levels, slightly lower BMI, decreased smoking, and sedentary habits, but higher alcohol consumption. Individuals with fPC3 scores representing early- plus late-day activity had a distinctly healthier lifestyle, marked by higher overall acceleration, decreased alcohol drinking and smoking habits, and lower sedentary behavior. Study participants with higher fPC4 scores (mid-day plus night-time activity) showed a slightly less healthy lifestyle with respect to increased tobacco use and sedentary lifestyle compared to individuals with lower fPC4 scores. Table 1 Baseline characteristics of UK Biobank participants in 2006–2010 (accelerometry in 2013–2015) by the first and fourth age-standardized quantile of fPC scores

Characteristics	fPC1	fPC2	fPC3	fPC4	
Q1	Q4	Q1	Q4	Q1	Q4	Q1	Q4	
Sex	N (%)/

mean (sd)

	N (%)/

mean (sd)

	N (%)/

mean (sd)

	N (%)/

mean (sd)

	N (%)/

mean (sd)

	N (%)/

mean (sd)

	N (%)/

mean (sd)

	N (%)/

mean (sd)

	
 Women	10,581 (49%)	12,484 (58%)	12,058 (56%)	11,093 (51%)	11,222 (52%)	11,764 (55%)	10,971 (51%)	12,063 (56%)	
 Men	10,983 (51%)	9079 (42%)	9506 (44%)	10,470 (49%)	10,342 (48%)	9799 (45%)	10,593 (49%)	9500 (44%)	
Age accelerometry, years	61.5 (7.9)	61.4 (7.8)	61.2 (7.8)	61.7 (7.9)	61.3 (7.9)	61.5 (7.7)	61.0 (7.8)	61.8 (7.8)	
Average overall acceleration, mg	19.5 (3.6)	38.3 (6.6)	30.7 (8.2)	29.5 (8.6)	30.7 (8.7)	29.4 (8.0)	29.6 (8.6)	30.3 (8.2)	
Light physical activity, min/week	1521.2 (469.9)	2646.3 (678.5)	2300.3 (708.2)	2102.0 (676.0)	2210.3 (733.9)	2145.0 (633.0)	2148.7 (697.5)	2201.9 (693.3)	
Moderate-to-vigorous physical activity, min/week	149.1 (130.0)	480.0 (301.9)	323.0 (253.4)	349.7 (269.7)	320.2 (245.7)	361.2 (280.1)	334.6 (259.3)	334.3 (260.3)	
Height, cm	170.2 (9.3)	168.6 (8.9)	169.2 (9.1)	169.5 (9.1)	169.7 (9.2)	169.2 (9.0)	170.0 (9.2)	168.9 (9.0)	
Body mass index, kg/m2	28.5 (5.3)	25.2 (3.6)	26.2 (4.3)	26.7 (4.4)	26.3 (4.4)	26.4 (4.1)	26.4 (4.3)	26.4 (4.3)	
Townsend Index of Deprivation	 − 1.4 (3.0)	 − 1.9 (2.7)	 − 1.6 (2.9)	 − 1.7 (2.8)	 − 1.5 (2.9)	 − 1.9 (2.7)	 − 1.8 (2.8)	 − 1.6 (2.9)	
Education level	
 Highest	9271 (43%)	9116 (43%)	10,265 (48%)	8070 (38%)	10,303 (48%)	8311 (39%)	9489 (44%)	9168 (43%)	
 Intermediate	5159 (24%)	4941 (23%)	5025 (24%)	5081 (24%)	4938 (23%)	5155 (24%)	5149 (24%)	4996 (23%)	
 Lowest	5040 (24%)	5512 (26%)	4715 (22%)	5827 (27%)	4708 (22%)	5832 (27%)	5217 (24%)	5215 (24%)	
 None of the above	1847 (8.7%)	1802 (8.4%)	1334 (6.3%)	2379 (11%)	1411 (6.6%)	2057 (9.6%)	1512 (7.1%)	1960 (9.2%)	
Alcohol intake, g/day	16.5 (18.5)	16.4 (15.9)	17.3 (17.6)	16.4 (17.2)	15.7 (16.6)	17.4 (17.2)	16.7 (17.0)	16.6 (17.1)	
Pack years, years	8.5 (16.0)	5.2 (11.1)	6.4 (13.1)	6.9 (13.6)	6.0 (12.9)	6.7 (12.9)	6.2 (12.7)	6.6 (13.1)	
Healthy diet score	3.5 (1.3)	3.9 (1.3)	3.7 (1.3)	3.7 (1.3)	3.8 (1.3)	3.7 (1.3)	3.7 (1.3)	3.7 (1.3)	
Sedentary behavior, h	4.9 (2.7)	3.8 (2.3)	4.1 (2.5)	4.4 (2.4)	4.0 (2.5)	4.4 (2.4)	4.1 (2.5)	4.3 (2.5)	
Cardiometabolic disease	
 No	17,538 (81%)	19,972 (93%)	19,301 (90%)	19,092 (89%)	19,156 (89%)	19,285 (89%)	19,232 (89%)	19,214 (89%)	
 Yes	4026 (19%)	1591 (7.4%)	2263 (10%)	2471 (11%)	2408 (11%)	2278 (11%)	2332 (11%)	2349 (11%)	
mg milligravity unit, sd standard deviation

Highest education: college or university; intermediate: A/AS, NVQ/HND/HNC or equivalent, other qualifications; lowest: O/GCSEs, CSEs or equivalent

We examined correlations between the four fPCs and circulating biomarkers and noted a weak positive correlation between day-long activity (fPC1) and high-density lipoprotein cholesterol (men: r = 0.21, women: r = 0.17), as well as a weak negative correlation with triglycerides (men: r =  − 0.13, women: r =  − 0.15) and a weak negative correlation with HbA1c among men (r =  − 0.13). There were no meaningful correlations with other biomarkers or with other fPCs (Additional file 1: Supplement S6).

Colorectal cancer risk

Increasing level of day-long activity (i.e., a 1-unit increase in the fPC1 score) showed an inverse association with colorectal cancer risk in the minimally adjusted model (HR = 0.92, 95% CI = 0.88–0.97). Multivariable adjustment had little impact on the relation (HR = 0.93, 95% CI = 0.88–0.98), and further adjustment for BMI yielded a similar result (HR = 0.94, 95% CI = 0.89–0.99). Ascending level of late-day activity (i.e., a 1-unit decrease in the fPC2 score) exhibited an inverse, but statistically non-significant relation with colorectal cancer, regardless of the degree of adjustment (HR = 0.93, 95% CI = 0.85–1.02). Conversely, an increasing level of early- plus late-day activity, instead of mid-day activity (i.e., a 1-unit decrease in the fPC3 score) was inversely associated with colorectal cancer in the minimally adjusted model (HR = 0.89, 95% CI = 0.80–0.99), and in the multivariable-models with and without additional adjustment for BMI (HR = 0.89, 95% CI = 0.80–0.99). Lastly, mid-day plus night-time activity (i.e., a 1-unit increase in the fPC4 score) showed no relation to colorectal cancer (Table 2). Table 2 Colorectal cancer risk (hazard ratios and 95% confidence intervals) for the four fPCs for models 1–3; N = 86,252, cases = 529

fPC	Activity timing	Model 1	Model 2	Model 3	
fPC1	Higher overall vs. lower overall	0.92, 0.88–0.97	0.93, 0.88–0.98	0.94, 0.89–0.99	
Non-linear p	0.059	0.077	0.095	
fPC2	Late-day vs. early-day	0.93, 0.85–1.02	0.93, 0.85–1.02	0.93, 0.85–1.02	
Non-linear p	0.647	0.573	0.569	
fPC3	Early/late-day vs. mid-day	0.89, 0.80–0.99	0.89, 0.80–0.99	0.89, 0.80–0.99	
Non-linear p	0.514	0.489	0.486	
fPC4	Mid-day/night vs. early/late-day	1.03, 0.88–1.20	1.02, 0.88–1.19	1.02, 0.88–1.19	
Non-linear p	0.275	0.285	0.292	
Model 1: Four fPCs and stratified by sex, age, study region; model 2: model 1 + cardiometabolic disease, height, smoking, alcohol intake, socio-economic status, education, sedentary behavior, healthy diet score, hormone replacement therapy, family history of colorectal cancer, and bowel cancer screening; model 3: model 2 + body mass index

fPC functional principal component

Note: Non-linear p-values were estimated by testing whether the coefficient of the second and third spline transformation equaled zero. To ease interpretation, hazard ratios for fPC1 and fPC4 are presented for a score comparison of + 1 vs. 0, while for fPC2 and fPC3, they are for a score of − 1 vs. 0

Sensitivity and interaction analyses

Separately considering colon (349 cases) and rectal cancers (180 cases), late-day activity (fPC2) showed no relation to colon cancer (HR = 0.96, 95% CI = 0.86–1.08), but was suggestively inversely associated with rectal cancer (HR = 0.88, 95% CI = 0.76–1.02) (model 3: p for difference = 0.369, Table 3). After excluding the first two years of follow-up, the association between day-long activity (fPC1) and colorectal cancer slightly weakened (HR for fPC1 = 0.94, 95% CI = 0.88–1.00), while the relation with early- plus late-day activity strengthened (HR for fPC3 = 0.83, 0.72–0.96, Additional file 1: Supplement S7). Limiting the analysis to never-smokers did not materially influence the inverse association between early- plus late-day activity (fPC3) and colorectal cancer, but the CIs were wider, now including the null value (HR = 0.87, 95% CI = 0.74–1.02, Additional file 1: Supplement S8). Excluding the term for cardiometabolic disease history from our models had no impact (HR for fPC1 = 0.94, 95% CI = 0.89–0.99; HR for fPC3 = 0.89, 95% CI = 0.80–0.99, Additional file 1: Supplement S9). Additionally accounting for shift work status also had no effect (Additional file 1: Supplement S10). Table 3 Colon and rectal cancer risk (hazard ratios and 95% confidence intervals) for the four fPCs for models 1–3

fPC	Activity timing	Model	Colon
Cases = 349	Rectum
Cases = 180	P for difference	
fPC1	Higher overall vs

lower overall

	Model 1	0.89, 0.84–0.95	0.97, 0.90–1.06	0.073	
Model 2	0.91, 0.85–0.96	0.97, 0.90–1.05	0.181	
Model 3	0.92, 0.86–0.98	0.97, 0.90–1.06	0.302	
fPC2	Late-day vs

early-day

	Model 1	0.96, 0.86–1.08	0.89, 0.77–1.03	0.398	
Model 2	0.96, 0.85–1.08	0.88, 0.76–1.02	0.381	
Model 3	0.96, 0.86–1.08	0.88, 0.76–1.02	0.369	
fPC3	Early/late-day vs

mid-day

	Model 1	0.88, 0.76–1.00	0.92, 0.77–1.10	0.654	
Model 2	0.88, 0.76–1.01	0.91, 0.77–1.10	0.735	
Model 3	0.88, 0.77–1.01	0.91, 0.77–1.09	0.746	
fPC4	Mid-day/night vs

early/late-day

	Model 1	1.03, 0.85–1.25	1.03, 0.80–1.32	0.994	
Model 2	1.02, 0.84–1.24	1.03, 0.80–1.32	0.950	
Model 3	1.02, 0.84–1.24	1.03, 0.80–1.32	0.953	
Model 1: Four fPCs and stratified by sex, age, study region; model 2: model 1 + cardiometabolic disease, height, smoking, alcohol intake, socio-economic status, education, sedentary behavior, healthy diet score, hormone replacement therapy, family history of colorectal cancer, and bowel cancer screening; model 3: model 2 + body mass index

fPC functional principal component

Note: To ease interpretation, hazard ratios for fPC1 and fPC4 are presented for a score comparison of + 1 vs. 0, while for fPC2 and fPC3, they are for a score of − 1 vs. 0

Interaction analyses revealed that day-long activity (fPC1) was inversely associated with colorectal cancer mainly in individuals who fell into the third quartile of sedentary behavior (HR = 0.87, 95% CI = 0.77–0.96), but not in those in the bottom quartile (HR = 0.98, 95% CI = 0.90–1.06; p for interaction = 0.036). Among women, day-long activity was inversely related to colorectal cancer in never-users of hormone therapy (HR = 0.88, 95% CI = 0.79–0.98), with no association in users (HR = 1.06, 95% CI = 0.95–1.19, p for interaction = 0.049) (Table 4, Additional file 1: Supplement S11). Table 4 Association of fPC1 with colorectal cancer risk by subgroups of sedentary behavior and hormone therapy

Sub analysis	N/cases	Hazard ratio
(95% confidence interval)	P for interaction	
fPC1 and sedentary behavior			0.036	
 Q1 (< 3 h)	35,395/194	0.98, 0.90–1.06		
 Q2 (3–4 h)	16,246/106	0.94, 0.84–1.06		
 Q3 (4–6 h)	21,374/132	0.87, 0.77–0.96		
 Q4 (> 6 h)	13,170/97	0.92, 0.81–1.05		
fPC1 and hormone therapy			0.049	
 No	30,709/125	0.88, 0.79–0.98		
 Yes	17,015/106	1.06, 0.95–1.19		
fPC functional principal component

Our fPCs were robust for variation in the bandwidths of the kernel smoother. When using an Epanechnikov kernel for smoothing, the explained variability was smaller for fPC1 (~ 18% decrease) and six components were necessary to reach the 95% threshold (Additional file 1: Supplement S12). However, the shapes of the first four fPCs were similar (Additional file 1: Supplement S13). fPCs were weakly to moderately correlated with accelerometer-derived physical activity intensities (Additional file 1: Supplement S14).

Discussion

Our primary finding was the identification of a two-peak pattern that was associated with reduced colorectal cancer risk, beyond the benefits of overall physical activity. That pattern of early- plus late-day activity (fPC3) was characterized by two distinct activity peaks: one in the morning at around 8AM and another in the afternoon at around 6PM. We also identified a pattern of late-day activity (fPC2), marked by a single peak in activity at approximately 6PM. However, that pattern was associated with a less pronounced decrease in colorectal cancer risk compared to the double peak pattern and did not reach statistical significance. The more pronounced benefit of the double peak activity pattern, as opposed to the single peak pattern, could be partially attributable to the advantage of distributing activities throughout both the morning and the afternoon, providing more comprehensive coverage of active time during the day.

Physical activity and colorectal cancer share a dose–response relationship, with additional benefits beyond the recommended levels of physical activity [34]. The evidence is strong enough to support a convincing causal association [18]. To our knowledge, this study is the first to use accelerometer data to examine fPCA-derived circadian physical activity patterns and their relationship to colorectal cancer risk.

Existing literature on timing of physical activity in relation to cancer is limited and includes only three studies. The first, a case–control study by Weitzer et al. [17], used interviewer-assessed physical activity data. It reported statistically non-significant decreased odds ratios of breast and prostate cancer with early morning activity but found no relation with mid-day or afternoon activity. The second, a prospective study by Feng et al., used UK Biobank accelerometer data and categorized physical activity into predetermined time intervals but observed no association with cancer mortality [9]. The third, a study by Bai et al., also used UK Biobank accelerometer data and it utilized k-means cluster analysis to discern circadian physical activity patterns. That study noted a reduced risk of colorectal cancer associated with activity in both the morning and afternoon [16], a finding that is consistent with our study results, supporting a potential benefit of a two-peak activity pattern in reducing colorectal cancer risk. We expand on this knowledge by using fPCA, which is not based on a priori assumptions, in contrast to the clustering method employed by Bai et al. Secondly, while Bai et al. compared the discrete membership of the double-peaked cluster with that of a consistently inactive subgroup—a comparison that may possibly increase the likelihood of statistical significance, we avoided this approach to maintain a more conservative analysis. Thirdly, we rigorously accounted for potential confounding variables through causal inference methods, providing a more robust analysis than Bai et al. Fourthly, unlike Bai et al., we included only participants with valid accelerometer data, ensuring the validity of our physical activity measurements. Finally, our study incorporated a more extensive range of sensitivity and interaction analyses than Bai et al., offering a more comprehensive understanding of the data. Considering the potential benefits of two-peak diurnal activity, it is important to note that the evidence on physical activity and health emphasizes that every move counts, regardless of intensity or duration [35]. In this regard, our findings suggest that instead of accumulating activity once a day, it may be better to engage in daily activity throughout the day.

In supplementary analyses, we observed that a day-long activity pattern (fPC1) was inversely associated with colorectal cancer risk particularly among individuals with higher levels of sedentary behavior. One possible explanation for this finding is that the apparent protective effect of physical activity becomes more pronounced when contrasted with prolonged periods of sedentary behavior. Previous investigations have not found that the physical activity and colorectal cancer relation is modified by sedentary behavior [36–39]. Of note, the general physical activity levels of the present cohort were relatively high. Therefore, individuals with less sedentary habits may exhibit an optimized cancer risk profile, leaving less room for further benefits from increased physical activity. Moreover, day-long activity (fPC1) seemed to be less relevant for rectal cancer, possibly due to less power in the rectal compared to the colon cancer analysis. However, the risk estimates for late-day activity (fPC2) were suggestively stronger for rectal than for colon cancer, hinting at a yet unknown link between physical activity and rectal cancer. Given the distinct relationships between the diurnal timing of physical activity and colon and rectal cancers, along with the varying carcinogenic processes for each type [40], future research is warranted to investigate diurnal timing of physical activity in relation to colorectal cancer according to anatomic subsite.

Among women, the day-long activity pattern was related to decreased colorectal cancer risk exclusively in those not using hormone therapy. In contrast, no association was observed in users of hormone therapy. Such interaction has been previously reported [41, 42]. Because estrogen is inversely linked to colorectal cancer [43], the observation of a risk gradient in the physical activity and colorectal cancer relation according to menopausal hormone therapy usage implies that physical activity may be associated with reduced colorectal cancer risk in part through a mechanism involving estrogen.

The biologic mechanisms underlying how the timing of daily activity affects cancer risk remain elusive. Animal studies show that the circadian clock regulates metabolic responses to exercise, and that the timing of exercise plays a pivotal role in enhancing the positive effects of exercise on metabolic pathways and energy balance [44, 45], which, in turn, is associated with cancer risk reduction [46]. Additionally, human skeletal muscle oxidative metabolism, influenced significantly by exercise, follows a circadian pattern, with peak strength and mitochondrial function occurring in the late afternoon [47, 48].

The primary etiologic pathway linking activity timing to colorectal cancer likely involves insulin resistance, a well-established colon cancer risk factor [49]. However, studies examining activity timing in relation to insulin resistance have yielded varying results. Some indicate that higher physical activity in the morning is associated with improved insulin resistance [13] or less incidence of obesity [50], while others suggest that afternoon or evening activity is related to improved insulin resistance [12] or greater reduction in fat mass [51]. Intervention studies consistently show that engaging in exercise in the afternoon or evening more strongly reduces blood glucose, insulin, and triglyceride levels, compared to other times of the day [6–8, 11], suggesting that late-day activity is the most probable protective factor.

Another biologic mechanism whereby the timing of physical activity may impact colorectal cancer risk is by decreasing chronic low-grade inflammation, a known contributor to carcinogenesis [3]. Inflammatory cytokines follow the circadian rhythm [52], and engaging in physical activity at specific times of the day is associated with reduced systemic inflammation [16].

Melatonin, which plays a significant role in both the circadian rhythm and in carcinogenesis [53], is influenced by rest-activity chronotypes. Nonetheless, the interaction between activity timing and melatonin secretion remains unclear [54].

On a methodological note, different data-driven methods to assess device-based timing of physical activity reveal fairly consistent physical activity time periods. Using clustering algorithms, a double peak pattern was identified [16] that was comparable to our fPC3, and others found a “late morning” pattern with a physical activity trajectory comparable to our early-day pattern (fPC2) [14]. In contrast, our fPCA avoids constraining individuals into an a priori defined number of discrete cluster and provides an understanding of the significance of each pattern by quantifying the amount of variance explained.

Strengths and limitations

The primary strength of our study lies in its novel exploration of diurnal activity timing in relation to colorectal cancer using fPCA. This method is free from pre-set assumptions about data structure, and it efficiently reduces data complexity and captures essential variation while maintaining the continuous nature of the data, rendering it ideal for understanding nuanced trends in time-series of raw accelerometry data. Capturing the entire range of acceleration signals provided us with a detailed perspective on overall activity timing. Another significant asset of our study is its large sample size, allowing us to perform a wide range of informative sub-analyses, confirming the robustness of our findings.

A limitation is our focus on hourly acceleration averages without distinguishing activity types or intensities, potentially masking certain aspects affecting colorectal cancer risk, such as the benefits of short bursts of vigorous activity [55]. The accelerometry data lacked contextual details, limiting insights into how different environments in which activity occurred could influence the impact of physical activity on colorectal cancer. Additionally, we did not examine whether chronotype or sleep patterns modified the association between activity timing and colorectal cancer. Case numbers were relatively low, especially in subgroup analyses, potentially masking true effects. UK Biobank is susceptible to selection bias [56] and the accelerometer subpopulation studied may exhibit healthy volunteer bias given the relatively high levels of activity [57, 58]. Finally, translating the fPCA findings into public health messages is challenging given the complexity of these analytic approaches. However, our results support physical activity recommendations that “every move counts.”

Conclusions

This study fills a crucial gap in our understanding of the role of physical activity in cancer prevention by contributing valuable data to the sparse literature on diurnal activity patterns and colorectal cancer risk. Leveraging raw accelerometer data and advanced statistical techniques, we uncovered a distinct pattern of activity during early and late parts of the day, which was associated with reduced risk of colorectal cancer, independent of overall activity. Should this finding be substantiated, physical activity timing could emerge as an innovative approach to prevent colorectal cancer. As such, the identification of specific times of the day when physical activity is most beneficial bears potential to shape cancer prevention programs. Nevertheless, further research is needed to corroborate the role of activity timing in cancer prevention.

Supplementary Information

Additional file 1: Supplement S1. Flowchart for inclusion and exclusion of participants. Supplement S2. Directed acyclic graph. Supplement S3. Covariates for Cox regression. Supplement S4. Missing information for covariates by fPC score quantiles. Supplement S5. Description of the physical activity patterns. Supplement S6. Correlation coefficients between fPCs and blood biomarkers. Supplement S7. Cox model results after exclusion of the first two years of follow-up. Supplement S8. Cox model results after restricting the analysis to never smokers. Supplement S9. Cox model results without adjustment for cardiometabolic disease status. Supplement S10. Cox model results with adjustment for shift work status. Supplement S11. Interaction terms for fPCs and covariates. Supplement S12. Sensitivity fPCA with different bandwidth estimations and kernel smoothers. Supplement S13. First four fPCs (A) and positive and negative scorers (B) when using an Epanechnikov kernel. Supplement S14. Correlation coefficients for fPCs and derived accelerometry.

Abbreviations

BMI Body mass index

CI Confidence interval

ENMO Euclidean norm minus one

fPCA Functional principal component analysis

fPC Functional principal component

HR Hazard ratio

ICD International Classification of Diseases

mg Milligravity unit

PACE Principal analysis by conditional estimation

Acknowledgements

This research has been conducted using the UK Biobank Resource under Application Number 55870 and we express our gratitude to the participants and those involved in building the resource. This work uses data provided by patients and collected by the NHS as part of their care and support, therefore for the data linkage we want to acknowledge NHS England (Copyright © (2023), NHS England. Re-used with the permission of the NHS England [and/or UK Biobank]. All rights reserved). This research used data assets made available by National Safe Haven as part of the Data and Connectivity National Core Study, led by Health Data Research UK in partnership with the Office for National Statistics and funded by UK Research and Innovation (research which commenced between 1st October 2020–31st March 2021 grant ref MC_PC_20029; 1st April 2021–30th September 2022 grant ref MC_PC_20058).

Disclaimer

Where authors are identified as personnel of the International Agency for Research on Cancer/World Health Organization, the authors alone are responsible for the views expressed in this article and they do not necessarily represent the decisions, policy, or views of the International Agency for Research on Cancer/World Health Organization.

Authors’ contributions

MJS and AW had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Study design: MJS, AW; Acquisition, analysis, or interpretation of the data: MJS, AW, HB, PB, AMS, MFL, JK, EF, HF, CMF, LPN, BF; Manuscript writing: MJS, MFL, AW; Critical revision of the manuscript for important intellectual content: HB, BF, HF, CMF, JK, AMS, MFL, AW. All authors read and approved the final manuscript.

Authors’ Twitter handles

Twitter handles: @MichaelJStein (Michael J. Stein).

Funding

Open Access funding enabled and organized by Projekt DEAL. Funding for IIG_FULL_2021_027 was obtained from World Cancer Research Fund (WCRF UK), as part of the World Cancer Research Fund International grant program. This study was supported by the French National Cancer Institute (l’Institut National du Cancer, INCA_16824), the German Research Foundation (BA 5459/2–1). The UK Biobank was supported by the Wellcome Trust, Medical Research Council, Department of Health, Scottish government, and Northwest Regional Development Agency. It has also had funding from the Welsh Assembly government and British Heart Foundation. The research was designed, conducted, analyzed, and interpreted by the authors entirely independently of these funding sources. The funder had no role in study design, data acquisition and analysis, decision to publish, or preparation of the manuscript.

Availability of data and materials

UK Biobank is an open access resource. Bona fide researchers can apply to use the UK Biobank dataset by registering and applying at http://ukbiobank.ac.uk/register-apply/.

Declarations

Ethics approval and consent to participate

Ethical approval was obtained from the North West Multi-Centre Research Ethics Committee (21/NW/0157). All participants provided written informed consent.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

1. Guthold R Stevens GA Riley LM Bull FC Worldwide trends in insufficient physical activity from 2001 to 2016: a pooled analysis of 358 population-based surveys with 1.9 million participants Lancet Glob Health 2018 6 10 e1077 e86 10.1016/S2214-109X(18)30357-7 30193830
Guthold R, Stevens GA, Riley LM, Bull FC. Worldwide trends in insufficient physical activity from 2001 to 2016: a pooled analysis of 358 population-based surveys with 1.9 million participants. Lancet Glob Health. 2018;6(10):e1077–86. 10.1016/S2214-109X(18)30357-7.30193830
2. World Health Organization Global status report on physical activity 2022 2022 Geneva World Health Organization
World Health Organization. Global status report on physical activity 2022. Geneva: World Health Organization; 2022.
3. Friedenreich CM Ryder-Burbidge C McNeil J Physical activity, obesity and sedentary behavior in cancer etiology: epidemiologic evidence and biologic mechanisms Mol Oncol 2021 15 3 790 800 10.1002/1878-0261.12772 32741068
Friedenreich CM, Ryder-Burbidge C, McNeil J. Physical activity, obesity and sedentary behavior in cancer etiology: epidemiologic evidence and biologic mechanisms. Mol Oncol. 2021;15(3):790–800. 10.1002/1878-0261.12772.32741068
4. Sato S Dyar KA Treebak JT Atlas of exercise metabolism reveals time-dependent signatures of metabolic homeostasis Cell Metab 2022 34 2 329 45.e8 10.1016/j.cmet.2021.12.016 35030324
Sato S, Dyar KA, Treebak JT, et al. Atlas of exercise metabolism reveals time-dependent signatures of metabolic homeostasis. Cell Metab. 2022;34(2):329–45.e8. 10.1016/j.cmet.2021.12.016.35030324
5. Janssen I, Campbell JJ, Zahran S, Saunders TJ, Tomasone JR, Chaput JP. Timing of physical activity within the 24-hour day and its influence on health: a systematic review. Health Promot. Chronic Dis. Prev. Can. 2022;42(4). 10.24095/hpcdp.42.4.02.
6. Kim H-K, Furuhashi S, Takahashi M, et al. Late-afternoon endurance exercise is more effective than morning endurance exercise at improving 24-h glucose and blood lipid levels. Front. Endocrinol. (Lausanne). 2022;13. 10.3389/fendo.2022.957239.
7. Qian J Xiao Q Walkup MP Association of Timing of Moderate-to-Vigorous Physical Activity With Changes in Glycemic Control Over 4 Years in Adults With Type 2 Diabetes From the Look AHEAD Trial Diabetes Care 2023 46 7 1417 1424 10.2337/dc22-2413 37226675
Qian J, Xiao Q, Walkup MP, et al. Association of timing of moderate-to-vigorous physical activity with changes in glycemic control over 4 years in adults with type 2 diabetes from the look AHEAD trial. Diabetes Care. 2023;46(7):1417–24. 10.2337/dc22-2413.37226675
8. Savikj M Gabriel BM Alm PS Afternoon exercise is more efficacious than morning exercise at improving blood glucose levels in individuals with type 2 diabetes: a randomised crossover trial Diabetologia 2019 62 2 233 237 10.1007/s00125-018-4767-z 30426166
Savikj M, Gabriel BM, Alm PS, et al. Afternoon exercise is more efficacious than morning exercise at improving blood glucose levels in individuals with type 2 diabetes: a randomised crossover trial. Diabetologia. 2019;62(2):233–7. 10.1007/s00125-018-4767-z.30426166
9. Feng H Yang L Liang YY Associations of timing of physical activity with all-cause and cause-specific mortality in a prospective cohort study Nat Commun 2023 14 1 930 10.1038/s41467-023-36546-5 36805455
Feng H, Yang L, Liang YY, et al. Associations of timing of physical activity with all-cause and cause-specific mortality in a prospective cohort study. Nat Commun. 2023;14(1):930. 10.1038/s41467-023-36546-5.36805455
10. Brito LC Peçanha T Fecchio RY Comparison of morning versus evening aerobic-exercise training on heart rate recovery in treated hypertensive men: a randomized controlled trial Blood Press Monit 2021 26 5 388 392 10.1097/mbp.0000000000000545 34001759
Brito LC, Peçanha T, Fecchio RY, et al. Comparison of morning versus evening aerobic-exercise training on heart rate recovery in treated hypertensive men: a randomized controlled trial. Blood Press Monit. 2021;26(5):388–92. 10.1097/mbp.0000000000000545.34001759
11. Moholdt T Parr EB Devlin BL Debik J Giskeødegård G Hawley JA The effect of morning vs evening exercise training on glycaemic control and serum metabolites in overweight/obese men: a randomised trial Diabetologia 2021 64 9 2061 2076 10.1007/s00125-021-05477-5 34009435
Moholdt T, Parr EB, Devlin BL, Debik J, Giskeødegård G, Hawley JA. The effect of morning vs evening exercise training on glycaemic control and serum metabolites in overweight/obese men: a randomised trial. Diabetologia. 2021;64(9):2061–76. 10.1007/s00125-021-05477-5.34009435
12. van der Velde JHPM Boone SC Winters-van Eekelen E Timing of physical activity in relation to liver fat content and insulin resistance Diabetologia 2023 66 3 461 471 10.1007/s00125-022-05813-3 36316401
van der Velde JHPM, Boone SC, Winters-van Eekelen E, et al. Timing of physical activity in relation to liver fat content and insulin resistance. Diabetologia. 2023;66(3):461–71. 10.1007/s00125-022-05813-3.36316401
13. Albalak G Stijntjes M Wijsman CA Timing of objectively-collected physical activity in relation to body weight and metabolic health in sedentary older people: a cross-sectional and prospective analysis Int J Obes 2022 46 3 515 522 10.1038/s41366-021-01018-7
Albalak G, Stijntjes M, Wijsman CA, et al. Timing of objectively-collected physical activity in relation to body weight and metabolic health in sedentary older people: a cross-sectional and prospective analysis. Int J Obes. 2022;46(3):515–22. 10.1038/s41366-021-01018-7.
14. Albalak G, Stijntjes M, van Bodegom D, et al. Setting your clock: associations between timing of objective physical activity and cardiovascular disease risk in the general population. Eur J Prev Cardiol. 2022. 10.1093/eurjpc/zwac239.
15. Qian J Walkup MP Chen SH Association of objectively measured timing of physical activity bouts with cardiovascular health in type 2 diabetes Diabetes Care 2021 44 4 1046 1054 10.2337/dc20-2178 33597215
Qian J, Walkup MP, Chen SH, et al. Association of objectively measured timing of physical activity bouts with cardiovascular health in type 2 diabetes. Diabetes Care. 2021;44(4):1046–54. 10.2337/dc20-2178.33597215
16. Bai P Ning X Gao R Association between circadian physical activity patterns and cancer incidence through regulation of inflammation: a UK biobank study Prev Med 2024 179 107831 10.1016/j.ypmed.2023.107831 38145876
Bai P, Ning X, Gao R, et al. Association between circadian physical activity patterns and cancer incidence through regulation of inflammation: a UK biobank study. Prev Med. 2024;179:107831. 10.1016/j.ypmed.2023.107831.38145876
17. Weitzer J Castaño-Vinyals G Aragonés N Effect of time of day of recreational and household physical activity on prostate and breast cancer risk (MCC-Spain study) Int J Cancer 2021 148 6 1360 1371 10.1002/ijc.33310 32976649
Weitzer J, Castaño-Vinyals G, Aragonés N, et al. Effect of time of day of recreational and household physical activity on prostate and breast cancer risk (MCC-Spain study). Int J Cancer. 2021;148(6):1360–71. 10.1002/ijc.33310.32976649
18. World Cancer Research Fund/American Institute for Cancer Research. Continuous Update Project Expert Report 2018: Physical activity and the risk of cancer. 2018.
19. Sudlow C Gallacher J Allen N UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age PLoS Med 2015 12 3 e1001779 10.1371/journal.pmed.1001779 25826379
Sudlow C, Gallacher J, Allen N, et al. UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3):e1001779. 10.1371/journal.pmed.1001779.25826379
20. Doherty A Jackson D Hammerla N Large scale population assessment of physical activity using wrist worn accelerometers: the UK Biobank study PLoS One 2017 12 2 e0169649 10.1371/journal.pone.0169649 28146576
Doherty A, Jackson D, Hammerla N, et al. Large scale population assessment of physical activity using wrist worn accelerometers: the UK Biobank study. PLoS One. 2017;12(2):e0169649. 10.1371/journal.pone.0169649.28146576
21. Zeitzer JM Blackwell T Hoffman AR Daily patterns of accelerometer activity predict changes in sleep, cognition, and mortality in older men J Gerontol A Biol Sci Med Sci 2017 73 5 682 687 10.1093/gerona/glw250
Zeitzer JM, Blackwell T, Hoffman AR, et al. Daily patterns of accelerometer activity predict changes in sleep, cognition, and mortality in older men. J Gerontol A Biol Sci Med Sci. 2017;73(5):682–7. 10.1093/gerona/glw250.
22. Yao F Müller H-G Wang J-L Functional data analysis for sparse longitudinal data J Am Stat Assoc 2005 100 470 577 590 10.1198/016214504000001745
Yao F, Müller H-G, Wang J-L. Functional data analysis for sparse longitudinal data. J Am Stat Assoc. 2005;100(470):577–90. 10.1198/016214504000001745.
23. James G Witten D Hastie T Tibshirani R An introduction to statistical learning: with applications in R 2021 2 New York Springer
James G, Witten D, Hastie T, Tibshirani R. An introduction to statistical learning: with applications in R. 2nd ed. New York: Springer; 2021.
24. Trehearne A Genetics, lifestyle and environment Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 2016 59 3 361 367 10.1007/s00103-015-2297-0 26753864
Trehearne A. Genetics, lifestyle and environment. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 2016;59(3):361–7. 10.1007/s00103-015-2297-0.26753864
25. UK Biobank. Data providers and dates of data availability. https://biobank.ndph.ox.ac.uk/showcase/exinfo.cgi?src=Data_providers_and_dates. Accessed 07 June 2023.
26. VanderWeele TJ Principles of confounder selection Eur J Epidemiol 2019 34 3 211 219 10.1007/s10654-019-00494-6 30840181
VanderWeele TJ. Principles of confounder selection. Eur J Epidemiol. 2019;34(3):211–9. 10.1007/s10654-019-00494-6.30840181
27. Bradbury KE Murphy N Key TJ Diet and colorectal cancer in UK Biobank: a prospective study Int J Epidemiol 2019 49 1 246 258 10.1093/ije/dyz064
Bradbury KE, Murphy N, Key TJ. Diet and colorectal cancer in UK Biobank: a prospective study. Int J Epidemiol. 2019;49(1):246–58. 10.1093/ije/dyz064.
28. Lourida I Hannon E Littlejohns TJ Association of lifestyle and genetic risk with incidence of dementia JAMA 2019 322 5 430 437 10.1001/jama.2019.9879 31302669
Lourida I, Hannon E, Littlejohns TJ, et al. Association of lifestyle and genetic risk with incidence of dementia. JAMA. 2019;322(5):430–7. 10.1001/jama.2019.9879.31302669
29. van Buuren S Groothuis-Oudshoorn K mice: multivariate imputation by chained equations in R J Stat Softw 2011 45 3 1 67 10.18637/jss.v045.i03
van Buuren S, Groothuis-Oudshoorn K. mice: multivariate imputation by chained equations in R. J Stat Softw. 2011;45(3):1–67. 10.18637/jss.v045.i03.
30. Harrell FE. Regression modeling strategies: With applications to linear models, logistic and ordinal regression, and survival analysis. 2nd ed. Cham: Springer; 2015.
31. R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2022. https://www.R-project.org/.
32. Gajardo A, Bhattacharjee S, Carroll C, et al. fdapace: functional data analysis and empirical dynamics. R package version 0.5.8. 2021. https://CRAN.R-project.org/package=fdapace.
33. Harrell F. rms: Regression Modeling Strategies. R package version 6.3–0. 2022. https://CRAN.R-project.org/package=rms.
34. Matthews CE Moore SC Arem H Amount and intensity of leisure-time physical activity and lower cancer risk J Clin Oncol 2020 38 7 686 697 10.1200/JCO.19.02407 31877085
Matthews CE, Moore SC, Arem H, et al. Amount and intensity of leisure-time physical activity and lower cancer risk. J Clin Oncol. 2020;38(7):686–97. 10.1200/JCO.19.02407.31877085
35. Bull FC Al-Ansari SS Biddle S World Health Organization 2020 guidelines on physical activity and sedentary behaviour Br J Sports Med 2020 54 24 1451 1462 10.1136/bjsports-2020-102955 33239350
Bull FC, Al-Ansari SS, Biddle S, et al. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med. 2020;54(24):1451–62. 10.1136/bjsports-2020-102955.33239350
36. Cong YJ Gan Y Sun HL Association of sedentary behaviour with colon and rectal cancer: a meta-analysis of observational studies Br J Cancer 2014 110 3 817 826 10.1038/bjc.2013.709 24263062
Cong YJ, Gan Y, Sun HL, et al. Association of sedentary behaviour with colon and rectal cancer: a meta-analysis of observational studies. Br J Cancer. 2014;110(3):817–26. 10.1038/bjc.2013.709.24263062
37. Morris JS Bradbury KE Cross AJ Gunter MJ Murphy N Physical activity, sedentary behaviour and colorectal cancer risk in the UK Biobank Br J Cancer 2018 118 6 920 929 10.1038/bjc.2017.496 29520109
Morris JS, Bradbury KE, Cross AJ, Gunter MJ, Murphy N. Physical activity, sedentary behaviour and colorectal cancer risk in the UK Biobank. Br J Cancer. 2018;118(6):920–9. 10.1038/bjc.2017.496.29520109
38. Nunez C Nair-Shalliker V Egger S Sitas F Bauman A Physical activity, obesity and sedentary behaviour and the risks of colon and rectal cancers in the 45 and up study BMC Public Health 2018 18 1 325 10.1186/s12889-018-5225-z 29510753
Nunez C, Nair-Shalliker V, Egger S, Sitas F, Bauman A. Physical activity, obesity and sedentary behaviour and the risks of colon and rectal cancers in the 45 and up study. BMC Public Health. 2018;18(1):325. 10.1186/s12889-018-5225-z.29510753
39. Shen D Mao W Liu T Sedentary behavior and incident cancer: a meta-analysis of prospective studies PLoS ONE 2014 9 8 e105709 10.1371/journal.pone.0105709 25153314
Shen D, Mao W, Liu T, et al. Sedentary behavior and incident cancer: a meta-analysis of prospective studies. PLoS One. 2014;9(8):e105709. 10.1371/journal.pone.0105709.25153314
40. Paschke S Jafarov S Staib L Are colon and rectal cancer two different tumor entities? A proposal to abandon the term colorectal cancer Int J Mol Sci 2018 19 9 2577 10.3390/ijms19092577 30200215
Paschke S, Jafarov S, Staib L, et al. Are colon and rectal cancer two different tumor entities? A proposal to abandon the term colorectal cancer. Int J Mol Sci. 2018;19(9):2577.30200215
41. Mai PL Sullivan-Halley J Ursin G Physical activity and colon cancer risk among women in the California teachers study cancer epidemiol Biomarkers Prev 2007 16 3 517 25 10.1158/1055-9965.EPI-06-0747
Mai PL, Sullivan-Halley J, Ursin G, et al. Physical activity and colon cancer risk among women in the California teachers study cancer epidemiol. Biomarkers Prev. 2007;16(3):517–25. 10.1158/1055-9965.EPI-06-0747.
42. Rennert G Rennert HS Pinchev M Lavie O Gruber SB Use of hormone replacement therapy and the risk of colorectal cancer J Clin Oncol 2009 27 27 4542 4547 10.1200/JCO.2009.22.0764 19704062
Rennert G, Rennert HS, Pinchev M, Lavie O, Gruber SB. Use of hormone replacement therapy and the risk of colorectal cancer. J Clin Oncol. 2009;27(27):4542–7. 10.1200/JCO.2009.22.0764.19704062
43. Barzi A Lenz AM Labonte MJ Lenz H-J Molecular pathways: Estrogen pathway in colorectal cancer Clin Cancer Res 2013 19 21 5842 5848 10.1158/1078-0432.CCR-13-0325 23965904
Barzi A, Lenz AM, Labonte MJ, Lenz H-J. Molecular pathways: estrogen pathway in colorectal cancer. Clin Cancer Res. 2013;19(21):5842–8. 10.1158/1078-0432.CCR-13-0325.23965904
44. Ezagouri S Zwighaft Z Sobel J Physiological and molecular dissection of daily variance in exercise capacity Cell Metab 2019 30 1 78 91.e4 10.1016/j.cmet.2019.03.012 31006590
Ezagouri S, Zwighaft Z, Sobel J, et al. Physiological and molecular dissection of daily variance in exercise capacity. Cell Metab. 2019;30(1):78–91.e4. 10.1016/j.cmet.2019.03.012.31006590
45. Sato S Basse AL Schönke M Time of exercise specifies the impact on muscle metabolic pathways and systemic energy homeostasis Cell Metab 2019 30 1 92 110.e4 10.1016/j.cmet.2019.03.013 31006592
Sato S, Basse AL, Schönke M, et al. Time of exercise specifies the impact on muscle metabolic pathways and systemic energy homeostasis. Cell Metab. 2019;30(1):92–110.e4. 10.1016/j.cmet.2019.03.013.31006592
46. Fay JR Steele V Crowell JA Energy homeostasis and cancer prevention: the AMP-activated protein kinase Cancer Prev Res (Phila) 2009 2 4 301 309 10.1158/1940-6207.CAPR-08-0166 19336731
Fay JR, Steele V, Crowell JA. Energy homeostasis and cancer prevention: the AMP-activated protein kinase. Cancer Prev Res (Phila). 2009;2(4):301–9. 10.1158/1940-6207.CAPR-08-0166.19336731
47. Gabriel BM Zierath JR Circadian rhythms and exercise — re-setting the clock in metabolic disease Nat Rev Endocrinol 2019 15 4 197 206 10.1038/s41574-018-0150-x 30655625
Gabriel BM, Zierath JR. Circadian rhythms and exercise — re-setting the clock in metabolic disease. Nat Rev Endocrinol. 2019;15(4):197–206. 10.1038/s41574-018-0150-x.30655625
48. van Moorsel D Hansen J Havekes B Demonstration of a day-night rhythm in human skeletal muscle oxidative capacity Mol Metab 2016 5 8 635 645 10.1016/j.molmet.2016.06.012 27656401
van Moorsel D, Hansen J, Havekes B, et al. Demonstration of a day-night rhythm in human skeletal muscle oxidative capacity. Mol Metab. 2016;5(8):635–45. 10.1016/j.molmet.2016.06.012.27656401
49. Komninou D Ayonote A Richie JP Rigas B Insulin resistance and its contribution to colon carcinogenesis Exp Biol Med 2003 228 4 396 405 10.1177/153537020322800410
Komninou D, Ayonote A, Richie JP, Rigas B. Insulin resistance and its contribution to colon carcinogenesis. Exp Biol Med. 2003;228(4):396–405. 10.1177/153537020322800410.
50. Chomistek AK Shiroma EJ Lee I-M The relationship between time of day of physical activity and obesity in older women J Phys Act Health 2016 13 4 416 418 10.1123/jpah.2015-0152 26445277
Chomistek AK, Shiroma EJ, Lee I-M. The relationship between time of day of physical activity and obesity in older women. J Phys Act Health. 2016;13(4):416–8. 10.1123/jpah.2015-0152.26445277
51. Di Blasio A Di Donato F Mastrodicasa M Effects of the time of day of walking on dietary behaviour, body composition and aerobic fitness in post-menopausal women J Sports Med Phys Fitness 2010 50 2 196 201 20585298
Di Blasio A, Di Donato F, Mastrodicasa M, et al. Effects of the time of day of walking on dietary behaviour, body composition and aerobic fitness in post-menopausal women. J Sports Med Phys Fitness. 2010;50(2):196–201.20585298
52. Scheiermann C Kunisaki Y Frenette PS Circadian control of the immune system Nat Rev Immunol 2013 13 3 190 198 10.1038/nri3386 23391992
Scheiermann C, Kunisaki Y, Frenette PS. Circadian control of the immune system. Nat Rev Immunol. 2013;13(3):190–8. 10.1038/nri3386.23391992
53. Talib WH Melatonin and Cancer Hallmarks Molecules 2018 23 3 518 10.3390/molecules23030518 29495398
Talib WH. Melatonin and cancer hallmarks. Molecules. 2018;23(3):518. 10.3390/molecules23030518.29495398
54. Montaruli A Galasso L Caumo A The circadian typology: the role of physical activity and melatonin Sport Sci Health 2017 13 3 469 476 10.1007/s11332-017-0389-y
Montaruli A, Galasso L, Caumo A, et al. The circadian typology: the role of physical activity and melatonin. Sport Sci Health. 2017;13(3):469–76. 10.1007/s11332-017-0389-y.
55. Stamatakis E Ahmadi MN Friedenreich CM Vigorous Intermittent Lifestyle Physical Activity and Cancer Incidence Among Nonexercising Adults: The UK Biobank Accelerometry Study JAMA Oncol 2023 9 9 1255 1259 10.1001/jamaoncol.2023.1830 37498576
Stamatakis E, Ahmadi MN, Friedenreich CM, et al. Vigorous intermittent lifestyle physical activity and cancer incidence among nonexercising adults: the UK Biobank accelerometry study. JAMA Oncol. 2023;9(9):1255–9. 10.1001/jamaoncol.2023.1830.37498576
56. Fry A Littlejohns TJ Sudlow C Comparison of Sociodemographic and Health-Related Characteristics of UK Biobank Participants With Those of the General Population Am J Epidemiol 2017 186 9 1026 1034 10.1093/aje/kwx246 28641372
Fry A, Littlejohns TJ, Sudlow C, et al. Comparison of sociodemographic and health-related characteristics of UK Biobank participants with those of the general population. Am J Epidemiol. 2017;186(9):1026–34. 10.1093/aje/kwx246.28641372
57. Ho FK Zhou Z Petermann-Rocha F Association between device-measured physical activity and incident heart failure: a prospective cohort study of 94 739 UK Biobank participants Circulation 2022 146 12 883 891 10.1161/CIRCULATIONAHA.122.059663 36036153
Ho FK, Zhou Z, Petermann-Rocha F, et al. Association between device-measured physical activity and incident heart failure: a prospective cohort study of 94 739 UK Biobank participants. Circulation. 2022;146(12):883–91. 10.1161/CIRCULATIONAHA.122.059663.36036153
58. Pearce M Strain T Kim Y Estimating physical activity from self-reported behaviours in large-scale population studies using network harmonisation: findings from UK Biobank and associations with disease outcomes Int J Behav Nutr Phys Act 2020 17 1 40 10.1186/s12966-020-00937-4 32178703
Pearce M, Strain T, Kim Y, et al. Estimating physical activity from self-reported behaviours in large-scale population studies using network harmonisation: findings from UK Biobank and associations with disease outcomes. Int J Behav Nutr Phys Act. 2020;17(1):40. 10.1186/s12966-020-00937-4.32178703
